SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-007065
Filing Date
2019-03-11
Accepted
2019-03-11 18:17:34
Documents
2
Period of Report
2019-03-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1611
2 EX-24 DOCUMENT attachment1.htm EX-24 4044
  Complete submission text file 0000899243-19-007065.txt   7106
Mailing Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114
Business Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114 617-622-4003
ZAFGEN, INC. (Issuer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ZAFGEN, INC. 175 PORTLAND STREET 4TH FL BOSTON MA 02114
Business Address
Singhal Priya (Reporting) CIK: 0001769608 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36510 | Film No.: 19673415